Lupus is a chronic disease that can cause inflammation and pain in any part of the body. It’s an autoimmune disease, which ...

Dr Sudhir Karmacharya, a lupus specialist at the National Center for Rheumatic Diseases (NECRD), stated that lupus is more ...

For the patient who presents with a new diagnosis of SLE, or for the one who has a flare in previously established disease, the immediate need is to achieve control of the inflammatory process.

The National Institutes of Health has awarded an Oklahoma Medical Research Foundation scientist a $4.1 million grant to study ...

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

AstraZeneca's Saphnelo has become the first new drug to be approved to treat the autoimmune disease systemic lupus erythematosus (SLE) in the EU for more than 10 years. The European Commission has ...

Healthy living is a goal for most. Yet, much too often individuals unknowingly engage in habits that hinder this goal.

A new study found that low or absent disease activity, hydroxychloroquine (HCQ) use, and gradual reduction of GC dosing can ...

Cutaneous lupus erythematosus is associated with an increased risk for ASCVD, similar to the risk seen in association with SLE.

Children with lupus nephritis who receive belimumab achieve treatment targets faster, and can taper glucocorticoids earlier, than those using standard immunotherapy, according to data published in ...

Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.

Objectives SLE is a multifaceted autoimmune disorder with a complex pathogenesis involving genetic, environmental and ...